Salesforce
CRM
$161.71
-1.73%
Salesforce, Inc. is the global leader in enterprise cloud computing, providing a comprehensive suite of customer relationship management (CRM) solutions through its Customer 360 platform. The company is the dominant force in the CRM software industry, known for pioneering the software-as-a-service model and building an extensive ecosystem around its core sales, service, marketing, and commerce clouds. The current investor narrative is dominated by the company's aggressive pivot to capitalize on the AI revolution, its massive $27 billion share repurchase plan signaling strong financial health, and a challenging market rotation where software stocks are under pressure despite the broader AI-driven tech rally, as evidenced by recent news of a painful rotation out of richly priced tech.…
CRM
Salesforce
$161.71
Related headlines
CRM 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $210.22 and implied upside of +30.0% versus the current price.
Average Target
$210.22
19 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
19
covering this stock
Price Range
$129 - $210
Analyst target range
Analyst coverage is substantial, with 11 analysts providing estimates, and the institutional ratings show a mix of Buy/Overweight and Hold/Neutral stances, indicating a cautiously optimistic but not uniformly bullish consensus. The average target price is not explicitly provided in the data, but the estimated EPS average for the forward period is $18.17, which, when combined with the forward PE of 10.67x, implies a rough price target in the $194 area, suggesting potential upside from the current $165.89 price, though this is a derived figure and not a direct consensus target. The target range among analysts appears wide, reflecting high uncertainty; the high EPS estimate of $18.75 and low of $17.86 show a relatively tight band for earnings, but the dispersion in stock price targets (implied by the variety of ratings from 'Buy' to 'Market Perform') signals divergent views on the appropriate multiple to apply, driven by debates over AI monetization, competitive pressures, and macroeconomic impacts on software spending.
CRM Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -37.85% and a 6-month decline of -36.74%, positioning it near the bottom of its 52-week range, currently trading at just $165.89 compared to a 52-week high of $276.80. This deep drawdown of -43.34% from its highs suggests the stock is in a value-seeking zone but remains a potential falling knife amid persistent selling pressure. Recent momentum shows a stark divergence, with a 1-month gain of +3.01% against the severe longer-term declines, indicating a potential technical rebound or short-term mean reversion attempt; however, the 3-month performance remains deeply negative at -13.97%, showing the nascent recovery is fragile and has not yet reversed the intermediate downtrend. Key technical levels are clear, with immediate support at the 52-week low of $161.40 and major resistance at the 52-week high of $276.80; a sustained break below $161.40 would signal a continuation of the bearish trend, while a move above the recent rebound high near $210 would be needed to suggest a more durable recovery. The stock's beta of 1.151 indicates it is approximately 15% more volatile than the broader market, which is relevant for risk management given its current high volatility and negative relative strength of -60.71% over the past year.
Beta
1.15
1.15x market volatility
Max Drawdown
-44.5%
Largest decline past year
52-Week Range
$161-$277
Price range past year
Annual Return
-38.7%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | -6.8% | +1.5% |
| 3m | -16.8% | +13.4% |
| 6m | -37.3% | +10.9% |
| 1y | -38.7% | +24.5% |
| ytd | -36.2% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Revenue growth remains robust but is showing signs of sequential deceleration; the most recent quarterly revenue (Q4 FY2026) was $11.20 billion, representing a 12.09% year-over-year increase, yet this growth rate has moderated from higher levels in prior quarters, as seen in the trend from $9.13B (Q1 FY2025) to the current $11.20B. The company is solidly profitable with a net income of $1.94 billion in the latest quarter and a strong gross margin of 77.61%, which has remained stable in the high-70% range across recent quarters; operating margins are also healthy at 21.87%, indicating efficient scaling of its cloud-based model. The balance sheet and cash flow position are exceptionally strong, with trailing twelve-month free cash flow of $14.40 billion, a manageable debt-to-equity ratio of 0.29, and a current ratio of 0.76; the massive FCF generation, coupled with the announced $27 billion buyback, underscores the company's ability to fund growth and return capital without straining its financial health, though the sub-1 current ratio warrants monitoring of short-term liquidity.
Quarterly Revenue
$11.2B
2026-01
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.77%
Latest Quarter
Free Cash Flow
$14.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
Given the positive net income of $1.94 billion, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 27.05x, while the forward PE is significantly lower at 10.67x, indicating the market expects substantial earnings growth in the coming year. Compared to the broader software industry, a trailing PE of 27.05x is elevated, suggesting the market still prices in a premium for Salesforce's market leadership and growth profile, despite the recent stock price collapse. Historically, the stock's own valuation has compressed dramatically; the current trailing PE of 27.05x is near the lower end of its multi-year range, having fallen from levels above 40x in early 2025, indicating the market has significantly de-rated the stock, which may present a value opportunity if growth expectations are met, but also reflects heightened concerns about growth deceleration and sector-wide multiple compression.
PE
27.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -2046x~1557x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple

